The interactions of the anthelmintic agent avermectin B la, the anticonvulsant pentobarbital, and the anxiolytic tracazolate with the y-aminobutyric acid (GABA) receptor-chloride ion channel complex in rat brain membrane were studied. The results indicated that they all potentiated ligand binding to the GABA and benzodiazepine receptors. The stimulatory effects of avermectin B1, and pentobarbital, but not tracazolate, on GABA receptor binding were inhibited by picrotoxin. The effect of avermectin B1, was not additive with those of tracazolate and pentobarbital. On the other hand, the stimulatory effect of GABA on benzodiazepine binding was additive with those of avermectin B1, and pentobarbital, but tracazolate and pentobarbital inhibited the effect of avermectin B1,. In receptor heat inactivation experiments, avermectin B1, and clonazepam protected GABA receptors, whereas avermectin B1, and GABA protected benzodiazepine receptors. Tracazolate, pentobarbital, and picrotoxin did not protect either receptor. These findings suggest that the recognition sites for the benzodiazepines, avermectin B la, tracazolate, pentobarbital, and picrotoxin are coupled allosterically to the GABA receptor -chloride ion channel complex in different ways. The binding site for avermectin B la may be partially shared by picrotoxin, pentobarbital, and tracazolate.
y-Aminobutyric acid (GABA) is an important inhibitory neurotransmitter in the mammalian central nervous system and in the invertebrate peripheral nervous system (Krnjevic, 1974; Takeuchi, 1976) . Evidence accumulated from studies of GABAergic function in the mammalian central nervous system indicates that compounds which activate the GABA receptor -chloride ion channel complex have the potential to be developed as useful drugs for treating anxiety, convulsion, epilepsy, and a variety of CNS disorders (Meldrum, 1978; Enna, 1980) . This hypothesis has gained support recently since several classes of anxiolytic compounds have been shown to interact with the GABA receptor complex. This complex is believed to consist of multiple recognition sites, including the binding sites for GABA and the benzodiazepines (Enna and Snyder, 1975; Squires and Braestrup, 1977; Mohler and Okada, 1977; Tallman et al., 1979) . Avermectin B1,, an anthelmintic (Egerton et al., 1979) and insecticidal agent (Ostlind et al., 1979) , has been shown to affect the GABAergic nervous system of invertebrates ' (Fritz et al., 1979; Kass et al., 1980) and to potentiate the muscle relaxant effect of diazepam in mice (Williams and Yarbrough, 1979) . It enhances the receptor binding of the benzodiazepines (Williams and Yarbrough, 1979; Pong, 1980; Pong et al., 1981) and GABA (Pong and Wang, 1980, 1982) . The anesthetic barbiturates have been reported recently to enhance GABA binding (Willow and Johnston, 1981; Olsen, 1981) and to potentiate GABA-enhanced benzodiazepine binding (Skolnick et al., 1980) . Another class of anxiolytic compounds, the pyrazolopyridines such as tracazolate, also has been shown to potentiate GABA binding (Placheta and Karobath, 1980; Meiners and Salama, 1980) as well as benzodiazepine binding (Beer et al., 1978; Williams and Risley, 1979; Salama and Meiners, 1980; Supavilai and Karobath, 1981) . Furthermore, the convulsant picrotoxin is known to interact with the GABA -benzodiazepine receptor complex (Ticku and Olsen, 1978; Olsen, 1981; Pong and Wang, 1980, 1982) . It inhibits the effects of avermectin B1, on lobster neuromuscular junction (Fritz et al., 1979) , on Ascaris nervous system (Kass et al., 1980) , and on GABA binding to rat brain membranes (Pong and Wang, 1982) .
In the present study, we examined the interactions of avermectin B1,, tracazolate, pentobarbital, and picrotoxin Preparation of rat brain synaptic membranes. The brains of the male adult Wistar rats were homogenized with a Teflon homogenizer at 0°C in 15 vol of 0.32 M sucrose, 0.5 mM CaC12, 1 mM MgC12, and 1 mM NaHC03 and centrifuged at 1,500 x g for 10 min, and the supernatant was recentrifuged at 17,000 X g for 10 min. The pellets were frozen for at least 3 hr, resuspended in 10 mM sodium phosphate buffer, pH 7.4, and centrifuged at 25,000 x g for 30 min. These steps were repeated five times and the final pellets were stored at -20°C.
Benzodiazepine receptor binding. The pellets were resuspended in 10 mM sodium phosphate buffer, pH 7.4, and 50+1 aliquots (25 pg of protein) were incubated in triplicate at 0°C with 0.5 nM [3H]flunitrazepam with or without drug in 0.95 ml of 50 mM Tris-Cl, pH 7.4, for 90 min. At the end of the incubation, the membranes were filtered on Whatman GF/B filters and washed two times with 5.0 ml of the ice cold Tris-Cl buffer. The radioactivity retained on the filter was determined in Aquasol 2 (New England Nuclear). Nonspecific binding was estimated in the presence of 10 PM unlabeled clonazepam and was subtracted from total binding to obtain the value for specific binding. GABA binding. The pellets were resuspended in 10 mM sodium phosphate buffer, pH 7.4, and 50+1 aliquots (50 pg of protein) were incubated in quadruplicate at 0°C with 10 nM [3H]GABA with or without drug in 0.95 ml of 50 mM Tris-Cl, pH 7.4, for 15 min. The incubation mixture then was filtered rapidly under vacuum through a Whatman GF/B filter and immediately washed with 7 ml of the ice cold Tris buffer. The radioactivity retained on the filter was determined in Aquasol 2. Nonspecific GABA binding was determined in the presence of lo-" M unlabeled GABA and normally contributed about 15 to 25% of the total binding.
Results
Interaction with GABA receptor binding. Avermectin Br, and tracazolate markedly enhanced specific ["HI GABA binding to rat brain synaptic membranes in a dose-dependent manner (Table I) . At 7 PM, avermectin Bi, increased the binding of r3H]GABA up to 80% over control (average, 55 -t 5%; n = 15). Tracazolate had a somewhat smaller effect than avermectin Br, at a higher concentration (33 PM). Pentobarbital had an even smaller effect at very high concentrations (200 to 500 FM) and it was variable in different membrane preparations (10 to 45%). Clonazepam had no apparent effect on [3H]GABA binding. Picrotoxin did not have any effect on control binding, but it blocked 80% and 91% of the stimulatory effects of avermectin B1, and pentobarbital, respectively (Table II) . Under similar conditions, picotoxin inhibited the tracazolate stimulation of [3H]GABA binding by only 9%. This suggests that avermectin Bi, and tracazolate may not act via a common site. The combination of avermectin B1, and either tracazolate or pentobarbital, each at the concentrations resulting in maximal stimulation, did not increase GABA binding further, suggesting that avermectin Br, may share, at least partially, the binding sites ofpentobarbital and tracazolate (Table III) .
Protection of GABA receptor from heat inactivation. To explore the specificity of the interactions of these compounds with GABA receptors, the synaptic mem- Time at 60°, mln
Interactions with benzodiazepine receptor binding. Avermectin B,, was the most potent compound tested in enhancing ["Hlflunitrazepam binding to synaptic membranes. Its EC& value was approximately 50-fold lower than that of GABA and lOO-and lOOO-fold lower than tracazolate and pentobarbital, respectively. Avermectin B1, also gave the greatest magnitude of enhancement of binding. Its enhancement was 100% more than that by GABA and 500% more than that by tracazolate or pentobarbital (Fig. 2) . Picrotoxin did not have any effect on C3H]flunitrazepam binding. To delineate further the mechanisms of potentiation by these compounds, combination experiments were performed (Table IV) . At concentrations which potentiate ["Hlflunitrazepam binding maximally, the combination of GABA (100 PM) with avermectin B1, (7 PM) or with pentobarbital(500 PM) were nearly additive but the effect of tracazolate (33 PM) was not consistently additive with that of GABA. However, the effects of pentobarbital and tracazolate were not additive with that of avermectin B1,. In fact, tracazolate inhibited the effect of avermectin Bla. The effects of pentobarbital and tracazolate were not additive. Protection of benzodiazepine receptor binding from heat inactivation. To study further the interactions of these compounds with benzodiazepine receptors, the synaptic membranes were heated to 60°C for various periods of time in 50 mM Tris-Cl, pH 7.4. The survival of r3H] flunitrazenam binding then was determined at 0°C. In control samples, benzodiazepine binding was inactivated with a tl/z of 1.9 + 0.2 min (Fig. 3) . The presence of avermectin B1, and GABA protected benzodiazepine receptors from heat inactivation. The tl/2 in the presence GABA, 0---0, 500 pM pentobarbital, A-A; 33 pM tracazolate, m 100 pM picrotoxin, X-X; 7 pM aVeI'meCtin B,, + 100 /tM GABA, @----%.
of avermectin B1, was 28.4 + 6.9 min. The tl12 in the presence of GABA was 16.0 + 3.3 min. The receptor was remarkably more stable in the presence of the combination of avermectin B1, and GABA with a t,/z more than 6 hr. In contrast, tracazolate, picrotoxin, and pentobarbital did not protect benzodiazepine receptors from inactivation.
Discussion
The present study indicates that the recognition sites for GABA, the benzodiazepines, avermectin Bl,, tracazolate, pentobarbital, and picrotoxin are all associated with the GABA receptor. chloride ion channel complex (also see Olsen, 1981, for review (Olsen, 1981) . Conformational changes of the GABA receptor complex may occur when the receptor binds different ligands under various experimental conditions and this could affect the interaction of picrotoxin with the GABA receptor complex. The occupancy of GABA or benzodiazepine receptors may affect the mode of binding for avermectin B1, or picrotoxin. Picrotoxin blocks the stimulatory effect of avermectin B1, on GABA binding but not that on benzodiazepine binding (Pong et al., 1981) . Conceivably, the occupation of benzodiazepine receptors by the ligand may lead to a conformation change such that the binding of picrotoxin may no longer hinder the effect of avermectin B1,. A temperature dependence of the actions of picrotoxin on the GABA. benzodiazepine receptor complex has been reported (Karobath et al., 1981) . It has been shown that picrotoxin abolishes the enhancement of GABA binding by pentobarbital (Table II; Willow and Johnston, 1981; Olsen, 1981) . In the present study, the potentiating effect of avermectin B1, on GABA binding also was inhibited by picrotoxin.
However, the binding sites of avermectin B1, and pentobarbital are apparently different since, in heat inactivation experiments, GABA receptors are protected by avermectin B1, but not by pentobarbital.
Furthermore, picrotoxin did not protect GABA receptors from heat inactivation. Unlike avermectm B1,, clonazepam was effective in the
